4,272
Views
22
CrossRef citations to date
0
Altmetric
Commentary

COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 4108-4111 | Received 14 May 2021, Accepted 01 Jul 2021, Published online: 22 Jul 2021

References

  • Sharun K, Tiwari R, Natesan S, Yatoo MI, Malik YS, Dhama K. International travel during the COVID-19 pandemic: implications and risks associated with ‘travel bubbles J Travel Med. 2020 Dec 23;27(8):taaa184. doi:10.1093/jtm/taaa184. PMID: 33009813; PMCID: PMC7665670.
  • Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ. Coronavirus Disease 2019-COVID-19. Clin Microbiol Rev. 2020 Jun 24;33(4):e00028–20. doi:10.1128/CMR.00028-20. PMID: 32580969; PMCID: PMC7405836.
  • Dye C, Mills MC. COVID-19 vaccination passports. Science. 2021 Mar 19;371(6535):1184. doi:10.1126/science.abi5245. PMID: 33737463.
  • The Lancet Microbe.Vaccine certificates: does the end justify the means? Lancet Microbe. 2021 Apr;2(4):e130. doi:10.1016/S2666-5247(21)00067-7. Epub 2021 Mar 30. PMID: 33817675; PMCID: PMC8009611.
  • Gostin LO, Cohen IG, Shaw J. Digital health passes in the age of COVID-19: are “vaccine passports” lawful and ethical? JAMA. 2021 Apr 7;325:1933. doi:10.1001/jama.2021.5283. Epub ahead of print. PMID: 33825831.
  • Chen LH, Freedman DO, Visser LG. COVID-19 immunity passport to ease travel restrictions? J Travel Med. 2020 Aug 20;27(5):taaa085. doi:10.1093/jtm/taaa085. PMID: 32463093; PMCID: PMC7313786.
  • Schlagenhauf P, Patel D, Rodriguez-Morales AJ, Gautret P, Grobusch MP, Leder K. Variants, vaccines and vaccination passports: challenges and chances for travel medicine in 2021. Travel Med Infect Dis. 2021 Mar-Apr;40:101996. doi:10.1016/j.tmaid.2021.101996. Epub 2021 Feb 23. PMID: 33631338; PMCID: PMC7899929.
  • Sharun K, Tiwari R, Dhama K, Emran TB, Rabaan AA, Mutair AA. Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies. Hum Vaccin Immunother. 2021:1–4. doi:10.1080/21645515.2021.1923350. (In Press).
  • Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020 Dec 31;383(27):2603–15. doi:10.1056/NEJMoa2034577. Epub 2020 Dec 10. PMID: 33301246; PMCID: PMC7745181.
  • Levine-Tiefenbrun M, Yelin I, Katz R, Herzel E, Golan Z, Schreiber L, Wolf T, Nadler V, Ben-Tov A, Kuint J, et al. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nat Med. 2021 Mar 29;27:790–92. doi:10.1038/s41591-021-01316-7. Epub ahead of print. PMID: 33782619.
  • Hall VJ, Foulkes S, Saei A, Andrews N, Oguti B, Charlett A, Wellington E, Stowe J, Gillson N, Atti A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet. 2021 May 8;397(10286):1725–35. doi:10.1016/S0140-6736(21)00790-X. Epub 2021 Apr 23. PMID: 33901423; PMCID: PMC8064668.
  • Leshem E, Lopman BA. Population immunity and vaccine protection against infection. Lancet. 2021 May 8;397(10286):1685–87. doi:10.1016/S0140-6736(21)00870-9. Epub 2021 Apr 23. PMID: 33901422; PMCID: PMC8064666.
  • Pawlowski C, Lenehan P, Puranik A, Agarwal V, Venkatakrishnan AJ, Niesen MJM, O'Horo JC, Virk A, Swift MD, Badley AD, et al. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. Med (NY). 2021 Jun 29. doi:10.1016/j.medj.2021.06.007. Epub ahead of print. PMID: 34223401; PMCID: PMC8238652.
  • Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2021 Feb;21(2):e26–e35. doi:10.1016/S1473-3099(20)30773-8. Epub 2020 Oct 27. PMID: 33125914; PMCID: PMC7837315.
  • Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 Mar 6;397(10277):881–91. doi:10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19. PMID: 33617777; PMCID: PMC7894131.
  • Sharun K, Dhama K. COVID-19 vaccine diplomacy and equitable access to vaccines amid ongoing pandemic. Arch Med Res. 2021 Apr 23:S0188-4409(21)00112–0. doi:10.1016/j.arcmed.2021.04.006. Epub ahead of print. PMID: 33941393; PMCID: PMC8062433.
  • Sharun K, Singh R, Dhama K. Oxford-AstraZeneca COVID-19 vaccine (AZD1222) is ideal for resource-constrained low- and middle-income countries. Ann Med Surg (Lond). 2021 May;65:102264 . doi:10.1016/j.amsu.2021.102264. Epub 2021 Mar 31. PMID: 33815783; PMCID: PMC8010342.
  • Sharun K, Dhama K. India’s role in COVID-19 vaccine diplomacy. J Travel Med. 2021 Apr 16;taab064. doi:10.1093/jtm/taab064.
  • CNN Travel. China opens its borders to foreigners who take Chinese shots, as geopolitical vaccine silos emerge. [accessed 2021 April 12]. https://edition.cnn.com/travel/article/covid-vaccine-travel-visa-rules-intl-hnk/index.html
  • World Health Organization. Interim guidance for developing a smart vaccination certificate. [accessed 2021 April 12]. https://www.who.int/publications/m/item/interim-guidance-for-developing-a-smart-vaccination-certificate
  • Osama T, Razai MS, Majeed A. Covid-19 vaccine passports: access, equity, and ethics. BMJ. 2021 Apr 1;373:n861. doi:10.1136/bmj.n861. PMID: 33795260.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.